BridgeBio could be an acquisition target, but current financial challenges and competition suggest a "Hold" rating until ...

Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Silence Therapeutics (SLN – Research Report) and keeping the price ...

The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat conditions like Huntington’s.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The failure of each of these key individuals to come and answer questions under oath spoke volumes in itself, but their collective silence is deafening. Today's result has been achieved only ...

The plot thickens in the messy legal battle between Blake Lively and Justin Baldoni, which began after the release of their film It Ends With Us. While both sides have accused the other of bad ...

Today, Donald Trump didn’t mention it at all. “I promise to swiftly end the war in Ukraine … I will have that settlement done within 24 hours.” That was Trump’s unequivocal statement at ...

Is Alnylam Pharmaceuticals (ALNY) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. Alnylam Pharmaceuticals is one of 1010 individual ...

Cemdisiran is under clinical development by Alnylam Pharmaceuticals and currently in Phase III for Myasthenia Gravis. According to GlobalData, Phase III drugs for Myasthenia Gravis have a 70% phase ...

This silence has sparked questions and speculation, particularly given Trump’s history of both criticizing and engaging with the crypto world. Also Read: Coinbase Launches Bitcoin-Backed Loans ...

WWE Hall of Famer John Bradshaw Layfield, more famously known as JBL, has broken his silence a few hours after appearing in a different wrestling promotion. The former WWE Champion made the ...